BPC-157 / TB-500
SKU：bpc-157-tb500
Price：USD 80.00
Product information
BPC-157 and TB-500 are combined in a 20 mg vial for comparative tissue-model research. BPC-157 is investigated in growth-factor-related pathways, while TB-500 is studied in actin-associated cell movement. Comparing combined conditions with individual compounds is the experimental rationale; that rationale does not establish a validated clinical effect for the complete formulation.
Product specifications
- Components
- BPC-157 + TB-500 (Thymosin Beta-4)
- BPC-157 Sequence
- 15 amino acids (Gly-Glu-Pro-Pro-Pro...)
- TB-500 Fragment
- 43-amino acid active region of Tβ4
- Form
- Lyophilized powder blend
- Purity
- ≥99% per component (HPLC verified)
- Testing
- Third-party HPLC, Mass Spec, Endotoxin
- Storage
- -20°C for long-term stability
- Solubility
- Water-soluble
- Strength
- 20mg
- Purity (HPLC)
- >99% (HPLC)
- Appearance
- White to off-white powder
- Stability
- 24 months from manufacture date when stored properly
Analysis report
BPC-157 + TB-500 20mg · 20mg · BTB-101926-10-10
BPC-157 + TB-500 20mg · 20mg · Not provided
BPC-157 / TB-500 20mg · 20mg · 6UC3KJ
BPC-157 10mg / TB-500 10mg · 10mg · BTB-090226-10
BPC-157 10mg + TB-500 10mg · 20mg · JNYTC5
BPC-157/TB-500 10mg/10mg · 10mg · BPTB20-052026-4
BPC-157 10mg + TB-500 10mg (Wolverine) · 10mg · ZY20V9
BPC-157/TB-500 10mg/10mg · 10mg/10mg · BPTB20-032026-1
BPC-157 10mg + TB-500 · 10mg · 1000001
Research information
Read the full BPC-157 / TB-500 research monograph
Research overview
BPC-157 and TB-500 are combined in a 20 mg vial for comparative tissue-model research. BPC-157 is investigated in growth-factor-related pathways, while TB-500 is studied in actin-associated cell movement. Comparing combined conditions with individual compounds is the experimental rationale; that rationale does not establish a validated clinical effect for the complete formulation.